Document is current
Any future updates will be listed below
-
Authors
Khoshnazar, S.M.
Dehghani, A.
Bagheri, F.
Pezeshki, S.
Yousefzadeh, G.
-
Funding
Funding for this research was provided by:
Kerman University of Medical Sciences
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Type 2 diabetes patients requiring empagliflozin in Southeast of Iran: Frequency and guideline adherence (2022–2023)
Journal Title: Hipertensión y Riesgo Vascular
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.hipert.2023.10.004
Content Type: article
Copyright: © 2024 SEH-LELHA. Published by Elsevier España, S.L.U. All rights reserved.
